People who tested positive for COVID-19 and at high risk for developing severe disease* may be eligible for Covid-19 oral antiviral pills. These treatments reduce the COVID-19 related hospitalization and death risk in non-hospitalized patients with mild to moderate COVID-19. They are most effective when started within 5 days of symptom onset. The FDA has authorized the emergency use of Paxlovid and Lagevrio for outpatient treatment against COVID-19.

*e.g., 65 years and older, lung disease, heart disease, obesity, diabetes, hypertension, immunosuppression.

Resource

Who is eligible to receive Covid-19 oral antiviral pills treatment?

Paxlovid is available to people who:

Have tested positive for COVID-19 and have not yet been admitted to the hospital and
Are high risk for developing severe COVID-19 and
Are 12 years of age or older (and at least 88 pounds)

Paxlovid treatment in non-hospitalized adults with mild to moderate COVID-19 within five days of symptom onset reduces the risk of hospitalization or death by 89%.

Lagevrio is available to people who:

Have tested positive for COVID-19 and have not yet been admitted to the hospital and
Are high risk for developing severe COVID-19 and
Have no alternative FDA-authorized COVID-19 treatment options accessible to them or that are clinically appropriate for them and
Are 18 years of age or older

Lagevrio treatment in non-hospitalized adults with mild to moderate COVID-19 within 5 days of symptom onset reduces the risk of hospitalization or death by 30%.

Resource!

Test to Treat Locations

Both Paxlovid and Lagevrio will be available by prescription. You can get tested, see a doctor and get your COVID-19 pills easily at a Test to Treat center in one step. Also, if you test positive your doctor can prescribe your medicine and any location in the tool can fill your prescription.

Use the test to treat locator tool to find locations with COVID-19 pills!

Covid-19 Test Locator